nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00863	0.062	CbGeAlD
Metixene—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00853	0.0613	CbGeAlD
Metixene—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.00831	0.0597	CbGeAlD
Metixene—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00822	0.0591	CbGeAlD
Metixene—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00776	0.0558	CbGeAlD
Metixene—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00721	0.0518	CbGeAlD
Metixene—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00695	0.0499	CbGeAlD
Metixene—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00675	0.0485	CbGeAlD
Metixene—CHRM4—brain—attention deficit hyperactivity disorder	0.0066	0.0474	CbGeAlD
Metixene—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00657	0.0472	CbGeAlD
Metixene—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.0065	0.0467	CbGeAlD
Metixene—HTR2C—midbrain—attention deficit hyperactivity disorder	0.00543	0.039	CbGeAlD
Metixene—CHRM5—brain—attention deficit hyperactivity disorder	0.00516	0.0371	CbGeAlD
Metixene—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00463	0.0333	CbGeAlD
Metixene—HTR2C—nervous system—attention deficit hyperactivity disorder	0.00446	0.0321	CbGeAlD
Metixene—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00446	0.032	CbGeAlD
Metixene—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.0043	0.0309	CbGeAlD
Metixene—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00422	0.0303	CbGeAlD
Metixene—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00406	0.0292	CbGeAlD
Metixene—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00377	0.0271	CbGeAlD
Metixene—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00363	0.0261	CbGeAlD
Metixene—CHRM2—brain—attention deficit hyperactivity disorder	0.00354	0.0254	CbGeAlD
Metixene—HTR2C—brain—attention deficit hyperactivity disorder	0.00341	0.0245	CbGeAlD
Metixene—Mirtazapine—HRH3—attention deficit hyperactivity disorder	0.00338	0.0652	CrCbGaD
Metixene—CHRM1—brain—attention deficit hyperactivity disorder	0.00322	0.0232	CbGeAlD
Metixene—Mirtazapine—ADRA2C—attention deficit hyperactivity disorder	0.00308	0.0595	CrCbGaD
Metixene—CHRM3—brain—attention deficit hyperactivity disorder	0.00288	0.0207	CbGeAlD
Metixene—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.00227	0.0437	CrCbGaD
Metixene—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.00207	0.0399	CrCbGaD
Metixene—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.00186	0.0359	CrCbGaD
Metixene—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.00176	0.0339	CrCbGaD
Metixene—Protriptyline—SLC6A4—attention deficit hyperactivity disorder	0.00172	0.0332	CrCbGaD
Metixene—Mirtazapine—DRD4—attention deficit hyperactivity disorder	0.00167	0.0323	CrCbGaD
Metixene—Maprotiline—SLC6A3—attention deficit hyperactivity disorder	0.00147	0.0283	CrCbGaD
Metixene—Mirtazapine—DRD3—attention deficit hyperactivity disorder	0.00144	0.0278	CrCbGaD
Metixene—Mirtazapine—SLC6A3—attention deficit hyperactivity disorder	0.00134	0.0259	CrCbGaD
Metixene—Mirtazapine—ADRA2A—attention deficit hyperactivity disorder	0.00132	0.0254	CrCbGaD
Metixene—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.00121	0.0233	CrCbGaD
Metixene—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.00117	0.0226	CrCbGaD
Metixene—Maprotiline—DRD2—attention deficit hyperactivity disorder	0.00109	0.0211	CrCbGaD
Metixene—Mianserin—DRD3—attention deficit hyperactivity disorder	0.00106	0.0204	CrCbGaD
Metixene—Mirtazapine—SLC6A4—attention deficit hyperactivity disorder	0.001	0.0194	CrCbGaD
Metixene—Mirtazapine—DRD2—attention deficit hyperactivity disorder	0.000998	0.0193	CrCbGaD
Metixene—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.000986	0.019	CrCbGaD
Metixene—Cyproheptadine—DRD2—attention deficit hyperactivity disorder	0.000968	0.0187	CrCbGaD
Metixene—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.000967	0.0186	CrCbGaD
Metixene—Quetiapine—DRD4—attention deficit hyperactivity disorder	0.000953	0.0184	CrCbGaD
Metixene—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.000896	0.0173	CrCbGaD
Metixene—Promazine—DRD4—attention deficit hyperactivity disorder	0.000876	0.0169	CrCbGaD
Metixene—Quetiapine—HTR1B—attention deficit hyperactivity disorder	0.000847	0.0163	CrCbGaD
Metixene—Maprotiline—HTR2A—attention deficit hyperactivity disorder	0.000843	0.0163	CrCbGaD
Metixene—Mesoridazine—DRD2—attention deficit hyperactivity disorder	0.000838	0.0162	CrCbGaD
Metixene—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	0.000833	0.0161	CrCbGaD
Metixene—Quetiapine—DRD3—attention deficit hyperactivity disorder	0.000822	0.0159	CrCbGaD
Metixene—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.000811	0.0156	CrCbGaD
Metixene—Quetiapine—DRD1—attention deficit hyperactivity disorder	0.000807	0.0156	CrCbGaD
Metixene—Mirtazapine—HTR2A—attention deficit hyperactivity disorder	0.000771	0.0149	CrCbGaD
Metixene—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	0.00075	0.0145	CrCbGaD
Metixene—Cyproheptadine—HTR2A—attention deficit hyperactivity disorder	0.000748	0.0144	CrCbGaD
Metixene—Promazine—DRD1—attention deficit hyperactivity disorder	0.000742	0.0143	CrCbGaD
Metixene—Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.000737	0.0142	CrCbGaD
Metixene—Mianserin—DRD2—attention deficit hyperactivity disorder	0.000733	0.0141	CrCbGaD
Metixene—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.000689	0.0133	CrCbGaD
Metixene—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	0.000647	0.0125	CrCbGaD
Metixene—Thioridazine—DRD2—attention deficit hyperactivity disorder	0.000632	0.0122	CrCbGaD
Metixene—Promethazine—DRD2—attention deficit hyperactivity disorder	0.000594	0.0115	CrCbGaD
Metixene—Quetiapine—DRD2—attention deficit hyperactivity disorder	0.000569	0.011	CrCbGaD
Metixene—Mianserin—HTR2A—attention deficit hyperactivity disorder	0.000567	0.0109	CrCbGaD
Metixene—HTR2C—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000544	0.000672	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000534	0.00066	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000533	0.000659	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000531	0.000657	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000528	0.000652	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000526	0.00065	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000525	0.000649	CbGpPWpGaD
Metixene—Promazine—DRD2—attention deficit hyperactivity disorder	0.000523	0.0101	CrCbGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000521	0.000644	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000514	0.000636	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000506	0.000625	CbGpPWpGaD
Metixene—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000499	0.000617	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000499	0.000617	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000499	0.000617	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000498	0.000615	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000494	0.000611	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000494	0.00061	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000492	0.000608	CbGpPWpGaD
Metixene—Thioridazine—HTR2A—attention deficit hyperactivity disorder	0.000488	0.00942	CrCbGaD
Metixene—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000487	0.000602	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000484	0.000598	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000473	0.000585	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00047	0.000581	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000468	0.000579	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000465	0.000575	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000464	0.000573	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00046	0.000569	CbGpPWpGaD
Metixene—Promethazine—HTR2A—attention deficit hyperactivity disorder	0.000459	0.00886	CrCbGaD
Metixene—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000459	0.000567	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000459	0.000567	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000457	0.000565	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000454	0.000562	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000453	0.00056	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000453	0.00056	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000444	0.000549	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000443	0.000548	CbGpPWpGaD
Metixene—Quetiapine—HTR2A—attention deficit hyperactivity disorder	0.000439	0.00848	CrCbGaD
Metixene—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000439	0.000542	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000437	0.00054	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000435	0.000538	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000435	0.000538	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000435	0.000538	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000431	0.000533	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000431	0.000533	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000431	0.000533	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00043	0.000532	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00043	0.000532	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00043	0.000531	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000428	0.000529	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000427	0.000527	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000426	0.000526	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000426	0.000526	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000425	0.000526	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000421	0.000521	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000418	0.000517	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000417	0.000516	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000417	0.000515	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000417	0.000515	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000414	0.000511	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000413	0.00051	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000412	0.000509	CbGpPWpGaD
Metixene—Promazine—HTR2A—attention deficit hyperactivity disorder	0.000404	0.00779	CrCbGaD
Metixene—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000402	0.000497	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000401	0.000495	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0004	0.000494	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000397	0.00049	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000396	0.00049	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000385	0.000475	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000376	0.000465	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000376	0.000464	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000375	0.000463	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000374	0.000462	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000372	0.00046	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000371	0.000459	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00037	0.000457	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000369	0.000457	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000368	0.000455	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000368	0.000455	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000366	0.000453	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000366	0.000453	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000365	0.000451	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000362	0.000447	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00036	0.000445	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000359	0.000444	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000358	0.000443	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000357	0.000441	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000351	0.000434	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000351	0.000433	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000349	0.000432	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000346	0.000428	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000344	0.000425	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00034	0.00042	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000338	0.000418	CbGpPWpGaD
Metixene—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000337	0.000417	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000337	0.000416	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000335	0.000415	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000334	0.000413	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000332	0.000411	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000328	0.000406	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000326	0.000403	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000324	0.0004	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000323	0.000399	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000323	0.000399	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000319	0.000394	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000318	0.000394	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000318	0.000393	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000315	0.000389	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000314	0.000389	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000306	0.000378	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000301	0.000371	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0003	0.000371	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000293	0.000363	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000293	0.000362	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000293	0.000362	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000292	0.000362	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000292	0.000361	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000291	0.000359	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00029	0.000358	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00029	0.000358	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000289	0.000357	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000286	0.000354	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000286	0.000353	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000286	0.000353	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000282	0.000349	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000281	0.000348	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000281	0.000347	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00028	0.000347	CbGpPWpGaD
Metixene—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000279	0.000345	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000279	0.000345	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000278	0.000344	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000278	0.000343	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000275	0.00034	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000273	0.000337	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000264	0.000326	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000263	0.000325	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00026	0.000321	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000259	0.000321	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000258	0.00032	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000256	0.000317	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000256	0.000316	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000254	0.000314	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000253	0.000313	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000252	0.000312	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000252	0.000312	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000251	0.000311	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000251	0.00031	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00025	0.000309	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00025	0.000309	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000249	0.000308	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000248	0.000306	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000247	0.000305	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000247	0.000305	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000246	0.000304	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000246	0.000304	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000244	0.000301	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000244	0.000301	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000244	0.000301	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000243	0.000301	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000243	0.0003	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000242	0.000299	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000241	0.000298	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000241	0.000297	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000239	0.000296	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000239	0.000295	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000236	0.000292	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000235	0.000291	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000235	0.00029	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000232	0.000287	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000228	0.000282	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000227	0.000281	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000227	0.000281	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000226	0.00028	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000226	0.000279	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000225	0.000278	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000224	0.000277	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000224	0.000277	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000223	0.000276	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000222	0.000274	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000221	0.000274	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000221	0.000274	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000221	0.000273	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000219	0.00027	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000214	0.000265	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000213	0.000263	CbGpPWpGaD
Metixene—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000207	0.000256	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000207	0.000256	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000206	0.000255	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000206	0.000255	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000206	0.000254	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000205	0.000254	CbGpPWpGaD
Metixene—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000204	0.000252	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000204	0.000252	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.0002	0.000247	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000198	0.000245	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000198	0.000244	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000196	0.000243	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000194	0.00024	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000191	0.000237	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00019	0.000235	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000188	0.000232	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000186	0.00023	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000184	0.000228	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000181	0.000223	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000173	0.000214	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000173	0.000214	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000171	0.000212	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000171	0.000211	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000169	0.000209	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000167	0.000207	CbGpPWpGaD
Metixene—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000166	0.000205	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000161	0.000199	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000159	0.000197	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000159	0.000196	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000158	0.000195	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000157	0.000194	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000156	0.000193	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.00019	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000151	0.000187	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00015	0.000185	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000149	0.000184	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000148	0.000183	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000144	0.000179	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000144	0.000178	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000143	0.000176	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000141	0.000174	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000139	0.000172	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000139	0.000171	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000137	0.00017	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000135	0.000167	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000134	0.000166	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000133	0.000164	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000132	0.000164	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000132	0.000163	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000131	0.000162	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000131	0.000162	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00013	0.000161	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000129	0.00016	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000127	0.000156	CbGpPWpGaD
Metixene—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000126	0.000155	CbGpPWpGaD
Metixene—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000125	0.000154	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000122	0.000151	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000121	0.00015	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000121	0.00015	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00012	0.000149	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.88e-05	0.000122	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.53e-05	0.000105	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.51e-05	0.000105	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.42e-05	0.000104	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.7e-05	8.29e-05	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.42e-05	7.94e-05	CbGpPWpGaD
Metixene—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	5.39e-05	6.66e-05	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.23e-05	6.47e-05	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.52e-05	5.59e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.51e-05	5.57e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.46e-05	5.52e-05	CbGpPWpGaD
